BioMEMS 2008

Microelectronics, which has led to the explosion of consumer electronics sales, could now bring its added value to the Life Science applications. The key challenge for microelectronics is to make complexity invisible and adapt it to the value chain and way of working of the life science industries

Microsystems technologies are changing the Life Sciences industry. New in vitro diagnostic systems, new therapy strategies, genetic diseases treatment, targeted and intelligent drug delivery, artificial pancreas, drug discovery processes? are health improvement promised to the future generations, enabled by semiconductor and MEMS technologies. The Life Sciences industry already faces critical challenges to take its way to its expected market.

To take part in this innovation process, it is very important to understand the technology and industrial trends by having a good comprehension on the current used technologies, their limits and advantages, the applications and the way the Life Sciences are working. Indeed, Life Science is a broad field including industries like drug discovery, in vitro diagnostic, medical devices, instrumentation? In the same way, the market is segmented by applications, technologies and medical use.

BioMEMS 2008 report answer the question: How Microsystems or Semiconductor companies could become key suppliers of the Life Sciences field?

The report will enable you to:

• Understand the life science market and define your strategy to address it
• Understand the main requirements in terms of regulation (FDA, CE?)
• Get an overview of the main techniques in use or under development and the trends for the coming years
• Understand the real added value of Microsystems and Semiconductor for the life science industry
• Understand the main MEMS and semiconductor Success stories in the Life Science market

BioMEMS report provides an introduction to molecular biology with basic concepts presentation to better understand the biology fields and challenges. It particularly describes biological materials (nucleic acids, proteins, peptides, etc...), their size scales and interaction to highlight and make understandable the biological complexity.

The report is bringing a lot of value to IC manufacturers, MEMS manufacturers, materials and equipment suppliers and system manufacturers to better understand the business potential, the technology status, the value chain of life science market and who is doing what for strategic and marketing decision making.

Exemple of companies analysed in this report: Affymetrix, Agilent, Aventis, bioMrieux, Infineon, microParts, Moto, Novartis, Philips, Psivida, STM?